Medicare changes could pain drugmakers

The latest proposal from the U.S. Centers for Medicare and Medicaid Services (CMS) may widen the circle of drugmakers who will be negatively affected.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news